发明名称 USES OF MONOCLONAL ANTIBODY 8H9
摘要 This invention provides a composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a suitable carrier. This invention provides a pharmaceutical composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a pharmaceutically acceptable carrier. This invention also provides an antibody other than the monoclonal antibody 8H9 comprising the complementary determining regions of monoclonal antibody 8H9 or a derivative thereof, capable of binding to the same antigen as the monoclonal antibody 8H9. This invention provides a substance capable of competitively inhibiting the binding of monoclonal antibody 8H9. This invention also provides an isolated scFv of monoclonal antibody 8H9 or a derivative thereof. This invention also provides the 8H9 antigen. This invention also provides a method of inhibiting the growth of tumor cells comprising contacting said tumor cells with an appropriate amount of monoclonal antibody 8H9 or a derivative thereof.
申请公布号 US2010310571(A1) 申请公布日期 2010.12.09
申请号 US20100797081 申请日期 2010.06.09
申请人 SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH 发明人 CHEUNG NAI-KONG V.
分类号 A61K39/395;A61P35/00;C07K16/00 主分类号 A61K39/395
代理机构 代理人
主权项
地址